Adverse event reporting and Bell's palsy risk after COVID-19 vaccination - Authors' reply
- PMID: 34717806
- PMCID: PMC8550904
- DOI: 10.1016/S1473-3099(21)00631-9
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination - Authors' reply
Conflict of interest statement
ICKW reports research funding from Amgen, Bristol Myers Squibb, Pfizer, Janssen, Bayer, GlaxoSmithKline, Novartis, the Hong Kong Research Grants Council, the Hong Kong Health and Medical Research Fund, the National Institute for Health Research in England, European Commission, and the National Health and Medical Research Council in Australia. ICKW also reports receiving speakers fees from Janssen and Medice, outside the submitted work. ICKW is also an independent non-executive director of Jacobson Medical in Hong Kong. EYFW has received research grants from the Food and Health Bureau of the Government of the Hong Kong Special Administrative Region (SAR), and the Hong Kong Research Grants Council, outside the submitted work. CSLC has received grants from the Food and Health Bureau of the Hong Kong Government, Hong Kong Research Grant Council, Hong Kong Innovation and Technology Commission, Pfizer, IQVIA, and Amgen, and personal fees from Primevigilance, outside the submitted work. XL has received research grants from the Food and Health Bureau of the Government of the Hong Kong SAR, research and educational grants from Janssen and Pfizer, internal funding from the University of Hong Kong, and consultancy fees from Merck Sharp & Dohme, outside the submitted work. EWYC reports honorarium from Hospital Authority, grants from the Hong Kong Research Grants Council, Research Fund Secretariat of the Food and Health Bureau, grants from National Natural Science Fund of China, Wellcome Trust, Bayer, Bristol Myers Squibb, Pfizer, Janssen, Amgen, Takeda, and the Narcotics Division of the Security Bureau of the Hong Kong SAR, outside the submitted work.
Comment on
-
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.Lancet Infect Dis. 2022 Jan;22(1):64-72. doi: 10.1016/S1473-3099(21)00451-5. Epub 2021 Aug 16. Lancet Infect Dis. 2022. PMID: 34411532 Free PMC article.
-
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination.Lancet Infect Dis. 2021 Nov;21(11):1490-1491. doi: 10.1016/S1473-3099(21)00646-0. Lancet Infect Dis. 2021. PMID: 34717804 Free PMC article. No abstract available.
-
Adverse event reporting and Bell's palsy risk after COVID-19 vaccination.Lancet Infect Dis. 2021 Nov;21(11):1491-1492. doi: 10.1016/S1473-3099(21)00621-6. Lancet Infect Dis. 2021. PMID: 34717805 Free PMC article. No abstract available.
References
-
- Man KK, Lau WC, Coghill D, et al. Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study. Lancet Child Adolesc Health. 2020;4:435–443. - PubMed
-
- Whitaker HJ, Paddy Farrington C, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006;25:1768–1797. - PubMed
-
- Weldeselassie YG, Whitaker HJ, Farrington CP. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect. 2011;139:1805–1817. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical